NORWAY – 3i acquires Active Pharmaceutical Ingredients for $395m
3i has backed the buyout of Active Pharmaceuticals Ingredients, an Oslo-based supplier and developer of pharmaceutical ingredients and division of NYSE-listed Alpharma Inc, for $395m.
More on Buyouts
Foresight reaps 3.5x money in Mowgli exit to TriSpan
Sale of Indian restaurant chain is the sixth exit from the firm’s first Regional Investment fund
SoftwareONE on PE watchlist amid take-private optimism
Switzerland-listed cloud technology group has been eyed by several buyout houses in recent months
Equistone to exit Acuity in sale to Permira
Sale of financial services research group follows process with early discussions between vendor and bidders
Main Capital exits Onventis in SBO to Keensight
Exit from Main Fund V comes three years after the GP acquired the Germany-based procurement technology company
Latest News
Bowmark bolsters investment team with two hires
Laura Clayfield and Raj Mukherji have joined the London-based mid-market sponsor
Capiton moves two assets to continuation vehicle; Fund V largely unrealised
Eurazeo and Unigestion among LPs in new fund for industrial tech businesses Raith and AEMtec
BlackRock mulls new vintage of private capital products for sophisticated retail investors in Europe
Global asset manager explores new generation of private market funds for wealthy individuals banking on positive uptake from retail investors
LDC outlines plans for new record year of deployment
Despite macro woes, sponsor wants to build up on last year’s pace of investment and exceed GBP 400m mark in 2023